Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Med Parazitol (Mosk) ; (6): 30-2, 1991.
Artigo em Russo | MEDLINE | ID: mdl-1818244

RESUMO

7 patients in the acute and 51 patients in the chronic stages of opisthorchiasis were treated with azynoks in daily dose 60 mg per kilo. The radical cure was achieved in 95.8 +/- 0.4% of cases. The wild side effects (headache, vertigo, nausea, fatigue) were registered in 51.7 +/- 9.1% of the cases, predominantly during the first hours of the treatment. The biochemical and immunological changes during the first 2 weeks after azynoks administration were analogues to those seen after biltricide and chloxyl (hexaparaxylol) treatment.


Assuntos
Opistorquíase/tratamento farmacológico , Praziquantel/uso terapêutico , Adolescente , Adulto , Animais , Anticorpos Anti-Helmínticos/sangue , Fezes/parasitologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Opistorquíase/sangue , Opistorquíase/parasitologia , Opisthorchis/imunologia , Opisthorchis/isolamento & purificação , Contagem de Ovos de Parasitas , Praziquantel/efeitos adversos
2.
Med Parazitol (Mosk) ; (4): 72-5, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2811752

RESUMO

Studies of the time course of the immune status characteristics after praziquantel treatment and of the nature of its side-effects on various groups of opisthorchiasis patients in the focus established significant differences in their immune response to specific treatment. The lack of alterations in the T- and B-immunity systems in aboriginal population of the focus may suggest its tolerance to helminthic antigens. The trend towards cellular immunity stimulation and a significant increase in the levels of circulating immune complexes and specific antibodies in the serum were observed in aboriginal population of the focus. The comers showed significant initial alterations of the immunity status before treatment, pointing to their sensitization to parasitic antigens. Suppression of the infection normalizes several cellular and humoral immunity characteristics--the number of T-helpers, T-lymphocytes, B-lymphocytes, Th/Tc indices, T-lymphocyte functional activity, thus eliminating immune depression. The increased IgG, CIC and specific antibody levels significantly exceeding the normal level, occurrence or enhancement of allergic reactions point to the necessity of performing a desensitizing therapy and using effective cholagogic drugs in the multimodality treatment to rapidly eliminate the parasitic antigen.


Assuntos
Reservatórios de Doenças , Opistorquíase/imunologia , Praziquantel/uso terapêutico , Adulto , Formação de Anticorpos/efeitos dos fármacos , Doença Crônica , Feminino , Humanos , Imunidade Celular/efeitos dos fármacos , Masculino , Opistorquíase/tratamento farmacológico , Opistorquíase/etnologia , Praziquantel/efeitos adversos , Sibéria
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA